Pharmafile Logo
Pharmafocus logo
Advanced Search

Avacta’s COVID-19 lateral flow test gains clinical validation

April 20, 2021
Manufacturing and Production COVID-19

Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …

News
Eli Lilly front sign

Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy

April 19, 2021
Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news

The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …

News

NICE launch ambitious five-year patient access strategy

April 19, 2021
Sales and Marketing NICE

NICE has unveiled its five-year plan to speed up patients’ access to the latest and most effective treatments with increased …

News

Sanofi signs €414 million deal for C4XD oral IL-17A inhibitor programme

April 19, 2021
Sales and Marketing Sanofi

Sanofi has signed an exclusive worldwide licensing agreement with C4X Discovery Limited for C4XD’s oral pre-clinical IL-17A inhibitor programme, which …

News

Sanofi multiple myeloma drug approved for second indication by EC

April 19, 2021
Sales and Marketing European Commission, Sanofi, Sarclisa, pharma, pharma news

The European Commission (EC) has approved a second indication of Sanofi’s Sarclisa drug for the treatment of adult patients with …

News
pfizer

Pfizer vaccine: Study finds increased breakthrough rates of South African variant

April 19, 2021
Sales and Marketing COVID-19, Pfizer, Vaccine, variant

A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 16, 2021
Medical Communications covid 19 news, covid-19 news, news roundup, pharma, pharma news

A number of new COVID-19 developments have dominated the news again this week: J&J’s vaccine for the virus has been …

News

MHRA grants marketing authorisation for new formulation of Tysabri

April 16, 2021
Medical Communications MHRA

Biogen UK has been granted marketing authorisation by the MHRA for a subcutaneous (SC) injection of Tysabri (natalizumab), for adults …

News

Merck cease development of $425 million COVID-19 treatment

April 16, 2021
Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news

Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.

News

EMA to begin review of GSK and Vir’s COVID-19 treatment

April 16, 2021
Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir

The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …

News
andrei_r_-_shutterstock_1935537274_720

Thermo Fisher to acquire PPD in $17 billion deal

April 16, 2021
Medical Communications thermo fisher

Medical device maker Thermo Fisher Scientific announced it would acquire contract research organisation PPD Inc for $17.4 billion, as it …

News
Gilead sign

Gilead’s bladder cancer drug gets FDA approval

April 15, 2021
FDA, Gilead, bladder cancer, bladder cancer treatment, pharma, pharma news

The FDA have granted accelerated approval to Gilead’s Trodelvy drug for the treatment of metastatic urothelial cancer (UC).

News
Roche building

Roche’s Evrysdi drug for SMA shown to significantly increase survival

April 15, 2021
PTC Therapeutics, Roche, pharma, pharma news, spinal muscular atrophy

Roche’s Evrysdi therapy for the treatment of children with type 1 spinal muscular atrophy (SMA) has been shown to increase …

News
nhs_old_hospital_1

First approved C5 complement inhibitor recommended by NICE for NHS use

April 15, 2021
NHS, NICE

NICE has recommended Ultomiris (ravulizumab) for use in the NHS for the treatment of paroxysmal nocturnal haemoglobinuria (PNH) in adult …

News

Novartis signs capacity and technology transfer agreement for Roche drug

April 15, 2021
Novartis, Roche, production

Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production of …

News

Antibiotic Research UK launches £200,000 research grant programme

April 15, 2021

Antibiotic Research UK (ANTRUK) has launched its 2021 Small research Grants/Career Development Awards scheme, the charity’s largest grants programme to …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 14, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen plenty of good and bad COVID-19 vaccine news; the EMA and CDC have launched investigations …

News

J&J vaccine halted in US due to blood clots

April 14, 2021
Research and Development CDC, COVID-19 vaccine, FDA, Janssen, Johnson & Johnson, pharma, pharma news

The CDC and FDA have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine in the …

News
merckwindow_web

TILT Biotherapeutics & MSD to collaborate on adenoviral cancer immunotherapy trial

April 14, 2021
Research and Development clinical trial, oncology

TILT Biotherapeutics today announced a clinical trial collaboration agreement with MSD, to evaluate TILT’s adenoviral cancer immunotherapy, TILT-123, in combination …

News
az

Forxiga accepted for use within NHS Scotland for chronic heart failure

April 14, 2021
Research and Development AstraZeneca, nhs scotland

AstraZeneca have announced that Forxiga (dapagliflozin) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025